Table 2.

Reported routes of transmission by year of birth in the HCV cohort (n = 52,853) and PLC count (n = 1,609).

Year of birth, number in cohort (% by row)
Route of transmissionTotal count (%)<19301930–19451945–19601960–19751975<
Blood/blood products2,416 (4.57)223 (9.23)538 (22.27)934 (38.66)529 (21.9)192 (7.95)
PLC (% in group)109 (4.51)23 (10.3)49 (9.1)30 (3.2)6 (1.1)1 (0.5)
Intravenous drug use21,384 (40.46)15 (0.07)581 (2.72)5,903 (27.6)6,963 (32.56)7,922 (37.05)
PLC (% in group)409 (1.9)1 (6.7)60 (10.3)311 (5.3)37 (0.5)0 (0)
Mother-to-child147 (0.28)0 (0)3 (2.04)7 (4.76)19 (12.93)118 (80.27)
PLC (% in group)3 (2.0)0 (0)1 (33.33)1 (14.2)1 (5.2)0 (0)
Nosocomial504 (0.95)17 (3.37)98 (19.44)188 (37.3)125 (24.8)76 (15.08)
PLC (% in group)9 (1.8)0 (0)3 (3.1)5 (2.7)1 (0.8)0 (0)
Occupational28 (0.05)1 (3.57)4 (14.29)17 (60.71)6 (21.43)0 (0)
PLC (% in group)1 (3.6)0 (0)1 (25)0 (0)0 (0)0 (0)
Other800 (1.51)4 (0.5)50 (6.25)267 (33.38)252 (31.5)227 (28.38)
PLC (% in group)26 (3.25)1 (25)7 (14)15 (5.6)3 (1.2)0 (0)
Sexual1,396 (2.64)0 (0)37 (2.65)427 (30.59)495 (35.46)437 (31.3)
PLC (% in group)24 (1.7)0 (0)4 (10.8)16 (3.7)4 (0.8)0 (0)
Unknown26,178 (49.53)967 (3.69)2,750 (10.51)11,845 (45.25)8,318 (31.77)2,298 (8.78)
PLC (% in group)1,028 (3.9)90 (9.3)288 (10.5)598 (5.0)50 (0.6)2 (0.09)
Total52,853 (100)1,227 (2.32)4,061 (7.68)19,588 (37.06)16,707 (31.61)11,270 (21.32)
PLC (% by row)1,609 (100)115 (7.15)413 (25.67)976 (60.66)102 (6.34)3 (0.19)
  • Note: Italic text indicates the number/percentage of PLC.